D Varshith1*, K Prasanna Lakshmi1, K Maniraju1, G Chandu Priya1, B Venkateswara Reddy2 and A Padma3
1B.Pharmacy, Sankar Reddy Institute of Pharmaceutical Sciences, AP, India
2Professor, Department of Pharmaceutics, Sankar Reddy Institute of Pharmaceutical Sciences, AP, India
3Assistant Professor, Department of Pharmaceutical analysis, Sankar Reddy Institute of Pharmaceutical Sciences, AP, India
*Corresponding Author: D Varshith, B.Pharmacy, Sankar Reddy Institute of Pharmaceutical Sciences, AP, India.
Received: June 05, 2020; Published: December 30, 2020
Brain tumours represent a group of neoplasms arising from brain tissue each with their own unique biology prognosis and treatment. Included in these groups are neoplasms not arising from brain parenchyma’s which encompass meningioma’s lymphomas and metastatic disease from other primary sources. Despite the diverse group of neoplasms represented, most intracranial tumours follow similar clinical presentations and diagnostic workups methods. The majority of primary brain tumours fall under the WHO classification scheme of tumours of neuro epithelial tissue. There are over 120 brain tumour classifications defined by the WHO, based on the tumour cell type and location, making this a very complex diagnosis. The present review mainly described that diagnosis and therapeutic advancements of few types of brain tumors.
Keywords: Brain Tumor; Neoplasm; Brain Parenchyma; Lympoma; Metastatic
Citation: D Varshith., et al. “An Updated Review on Types of Brain Tumor".Acta Scientific Pharmacology 2.1 (2020): 18-19.
Copyright: © 2020 D Varshith., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.